WCM
MRNA icon

Westend Capital Management’s Moderna MRNA Stock Holding History

Westend Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$51 – 280
2026
Q1 		$51 Buy
+1
New +$47 ﹤0.01% 253
2024
Q2 		– Sell
-7
Closed -$746 – 289
2024
Q1 		$746 Buy
+7
New +$706 ﹤0.01% 290

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Westend Capital Management's MRNA Position: Q2 2026 in Review

Westend Capital Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 1 share — an estimated $51 sold.

Westend Capital Management first reported a position in MRNA in Q1 2024 and held it in 2 quarters. The position peaked at $746 in Q1 2024. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Westend Capital Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Westend Capital Management sold 1 Moderna share in Q2 2026, an estimated $51.
  • Westend Capital Management first reported a position in Moderna in Q1 2024 and held it in 2 quarters.
  • Westend Capital Management's Moderna position peaked at $746 in Q1 2024.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Westend Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.